MRK
Merck & Company Inc
147.20$
+1.5%
vs. previous close
Closing price · As of: Sep 17, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -6.5% | +0.8% | +0.8% | +5.4% | -7.5% | +6.1% | +17.3% | +21.7% | +1.4% | +6.7% | +1.2% | |
| – | -10.9% | -6.1% | -8.0% | +4.6% | -11.1% | +13.3% | +0.1% | +27.8% | -7.4% | -5.8% | +19.8% | |
| – | -3.6% | +4.9% | +5.6% | +5.8% | -5.8% | +2.9% | +25.7% | +19.4% | +5.1% | +11.3% | -4.6% | |
| – | -6.6% | +53.1% | +0.8% | -5.7% | -0.3% | +37.8% | -8.6% | +10.6% | +125.4% | -41.2% | -30.2% | |
| – | -11.1% | -97.5% | -4.3% | +3,179.5% | +8.9% | -22.3% | +9.4% | +0.9% | +1.5% | +1.5% | +37.8% | |
| – | -9.4% | +19.2% | +0.7% | -2.7% | -3.4% | +16.5% | -2.1% | +7.8% | +74.0% | -29.9% | -19.2% | |
| – | +12.9% | -27.1% | +23.6% | +31.4% | -11.3% | -30.0% | +137.9% | +38.5% | -83.8% | +584.5% | +16.1% | |
| – | -8.2% | +3.1% | +8.8% | +2.4% | +15.7% | -6.9% | -3.0% | +19.4% | +19.1% | +10.9% | +6.8% | |
| – | -68.7% | -13.7% | +40.0% | +33.4% | -17.6% | -18.2% | +136.7% | +18.5% | -88.5% | +955.4% | +5.7% | |
| – | -82.4% | -23.8% | +471.4% | -38.9% | -37.6% | -14.4% | +13.5% | +26.1% | -21.2% | +85.4% | +0.0% | |
| – | -62.7% | -11.8% | -38.9% | +159.8% | +58.2% | -28.2% | +84.6% | +11.3% | -97.5% | +4,589.6% | +6.6% | |
| – | -49.6% | -13.1% | +10.4% | +17.1% | -18.7% | -10.5% | +75.8% | +19.1% | -67.6% | +272.2% | +9.9% |
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.